ARTICLE | Product Development
Going ‘Golden’: K-Biotech may be prepping for its moment on the global stage
Korean biotech is punching above its weight with first-in-class programs and Western deals
March 27, 2026 5:59 PM UTC
The buzz in the hallways of the Westin Josun Seoul, where BioCentury and BayHelix hosted their fifth East-West Biopharma Summit this month, had one clear message: Korean biotech has begun to arrive on the global stage.
A March 12 announcement by Korea’s Ministry of Health and Welfare that Eli Lilly and Co. (NYSE:LLY) will invest $500 million in the country over the next five years underscored that point...